Screener / SEC EDGAR /CIK 0000352915 /10-K filed Feb 25, 2026, compared with Feb 26, 2025 /Numbers from the XBRL of the 10-Ks

NYSE Health care · Hospitals

Universal Health Services UHS

New risk paragraphs 7 Not in last year's 10-K Accounting checks 0 worth reading about, of 10 checks Insider buys 0 open-market, last 90 days Filings 2 in the last 30 days

Compare with peers Embed

Excel CSV Email alerts

UHS among the 162 companies we cover

Where it stands · the better end on the right. The band holds the middle half; the line is the median.

All 162

Sales growth

+4.8%+20.2%

+9.7%84th of 155 · median +10.5%

Net margin

-4.1%15.3%

8.0%72nd of 154 · median 6.8%

Return on equity

-5.2%18.5%

19.2%34th of 144 · median 9.2%

Free cash flow margin

2.3%19.2%

6.1%92nd of 145 · median 10.0%

Debt / equity (less is better)

1.160.42

0.7562nd of 108 · median 0.69

UHS and 9 peers, year by year

The 9 Health care companies closest to UHS in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

5 years 10 years Download CSV

Choose the peers

Health care companies (up to 9):

A ABBV ABT ACAD ACHC ADMA ADUS AGIO ALGN ALKS ALNY AMGN AMRX AXSM BAX BBIO BCRX BDX BEAM BHC BIIB BKD BMRN BMY BSX BTSG CAH CAI CGON CHE CI CNC CON COO COR CORT CRL CRSP CVS CYTK DGX DHR DVA DXCM EHC ELAN ELV ENOV ENSG EW EXEL GEHC GH GILD GKOS GMED GRAL HAE HALO HCA HIMS HSIC HUM ICUI IDXX IDYA ILMN INCY INSM INSP IONS IQV IRTC ISRG ITGR JAZZ JNJ KRYS KYMR LGND LH LIVN LLY LMAT LNTH MCK MDGL MDLN MDT MEDP MIRM MMSI MRK MRNA MSA MTD NBIX NTRA NVST OCUL OGN ONC OPCH PBH PCVX PEN PFE PGNY PODD PRCT PRGO PRVA PTGX QDEL RARE RDNT REGN RGEN RMD ROIV RPRX RVMD RVTY RXRX RYTM SGRY SHC SMMT SOLV SRPT SRRK STE SUPN SYK TARS TECH TEVA TFX TGTX THC TMDX TMO TWST UFPT UNH UTHR VCEL VCYT VEEV VKTX VRTX VTRS WAT WGS WRBY WST XENE XRAY ZBH ZLAB ZTS

Or type tickers, any sector:

Each company's latest fiscal year
Company	Year	Revenue	Sales growth	Gross margin	Operating margin	Net margin	FCF margin	Return on equity	Debt / equity
UHS Universal Health Services	FY2025	$17.4B	+9.7%	-	11.5%	8.6%	4.9%	20.5%	0.66
IQV IQVIA	FY2025	$16.3B	+5.9%	-	13.4%	8.3%	12.6%	20.9%	2.42
TEVA Teva Pharmaceutical Industries Ltd	FY2025	$17.3B	+4.3%	51.8%	12.5%	8.2%	6.7%	17.8%	2.12
REGN Regeneron Pharmaceuticals	FY2025	$14.3B	+1.0%	-	24.9%	31.4%	28.4%	14.4%	0.06
BSX Boston Scientific	FY2025	$20.1B	+19.9%	69.0%	18.0%	14.4%	18.2%	12.0%	0.47
BTSG BrightSpring Health Services, Inc.	FY2025	$12.9B	+28.2%	11.8%	2.3%	1.5%	3.1%	10.2%	1.34
GEHC GE HealthCare	FY2025	$20.6B	+4.8%	40.0%	13.4%	10.1%	7.3%	20.1%	1.01
VTRS Viatris	FY2025	$14.3B	−3.0%	35.1%	−18.6%	−24.6%	13.5%	−23.9%	0.98
LH Labcorp	FY2025	$14.0B	+7.2%	28.8%	9.9%	6.3%	8.6%	10.2%	0.65
THC Tenet Healthcare Corp	FY2025	$21.3B	+3.1%	-	16.5%	6.6%	11.9%	33.3%	3.12

Revenuepeer median $16.3B

Sales growthpeer median +4.8%

Gross marginpeer median 37.5%

BSX 69.0%
TEVA 51.8%
GEHC 40.0%
VTRS 35.1%
LH 28.8%
BTSG 11.8%
UHS -
IQV -
REGN -
THC -

Operating marginpeer median 13.4%

Net marginpeer median 8.2%

FCF marginpeer median 11.9%

Return on equitypeer median 14.4%

Debt / equitypeer median 1.01

Each company, year by year

Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2016 to FY2025 · 10-K XBRL

UHSUniversal Health Services

Revenue$17.4B Growth+9.7% Net margin8.6%

IQVIQVIA

Revenue$16.3B Growth+5.9% Net margin8.3%

TEVATeva Pharmaceutical Industries Ltd

Revenue$17.3B Growth+4.3% Net margin8.2%

REGNRegeneron Pharmaceuticals

Revenue$14.3B Growth+1.0% Net margin31.4%

BSXBoston Scientific

Revenue$20.1B Growth+19.9% Net margin14.4%

BTSGBrightSpring Health Services, Inc.

Revenue$12.9B Growth+28.2% Net margin1.5%

GEHCGE HealthCare

Revenue$20.6B Growth+4.8% Net margin10.1%

VTRSViatris

Revenue$14.3B Growth−3.0% Net margin−24.6%

LHLabcorp

Revenue$14.0B Growth+7.2% Net margin6.3%

THCTenet Healthcare Corp

Revenue$21.3B Growth+3.1% Net margin6.6%

Who rewrote the most

Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before

LH 48% · 22% TEVA 26% · 32% BSX 16% · 32% GEHC 14% · 32% REGN 20% · 21% THC 16% · 24% UHS 16% · 22% VTRS 16% · 22% BTSG 17% · 20% IQV 7% · 14%

Risk FactorsMD&AEach company's latest 10-K, so the dates differ. A company that rewrote much may have reorganized the text.

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

UHS is the bold green line; each peer has its own colour and dash, named at the line's end. Each company's first year in the window is 100, on a log scale: a line twice as high has doubled. A gap is a year with no number. A ring marks where a line starts: BTSG, GEHC, VTRS have no earlier 10-K here. REGN, BTSG, LH: the line is cut where a later 10-K restates the year before (a spin-off or a merger), so the two years are not the same company.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
UHS Dec	$9.8B	$10.4B	$10.8B	$11.4B	$11.6B	$12.6B	$13.4B	$14.3B	$15.8B	$17.4B
IQV Dec	$6.9B	$9.7B	$10.4B	$11.1B	$11.4B	$13.9B	$14.4B	$15.0B	$15.4B	$16.3B
TEVA Dec	$21.9B	$22.4B	$18.3B	$16.9B	$16.7B	$15.9B	$14.9B	$15.8B	$16.5B	$17.3B
REGN Dec	$4.9B	$5.9B	$5.1B	$6.6B	$8.5B	$16.1B	$12.2B	$13.1B	$14.2B	$14.3B
BSX Dec	$9.1B	$9.0B	$9.8B	$10.7B	$9.9B	$11.9B	$12.7B	$14.2B	$16.7B	$20.1B
BTSG Dec	-	-	-	-	-	-	$7.7B	$7.7B	$10.1B	$12.9B
GEHC Dec	-	-	-	-	-	$17.6B	$18.3B	$19.6B	$19.7B	$20.6B
VTRS Dec	-	-	$11.4B	$11.5B	$11.9B	$17.9B	$16.3B	$15.4B	$14.7B	$14.3B
LH Dec	$9.6B	$10.3B	$11.3B	$11.6B	$14.0B	$13.1B	$11.9B	$12.2B	$13.0B	$14.0B
THC Dec	$21.1B	$20.6B	$18.3B	$18.5B	$17.6B	$19.5B	$19.2B	$20.6B	$20.7B	$21.3B
Peer median	$9.3B	$10.0B	$11.3B	$11.5B	$11.9B	$16.0B	$14.4B	$15.0B	$15.4B	$16.3B

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

UHS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −24.3% to +89.1%. A gap is a year with no number. A ring marks where a line starts: BTSG, GEHC, VTRS, THC have no earlier 10-K here.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
UHS Dec	+8.0%	+6.6%	+3.5%	+5.6%	+1.6%	+9.4%	+6.0%	+6.6%	+10.8%	+9.7%
IQV Dec	+19.9%	+42.4%	+7.3%	+6.5%	+2.4%	+22.1%	+3.9%	+4.0%	+2.8%	+5.9%
TEVA Dec	+11.5%	+2.2%	−16.4%	−7.6%	−1.4%	−4.7%	−6.0%	+6.2%	+4.4%	+4.3%
REGN Dec	+18.4%	+20.8%	+14.3%	+27.4%	+29.6%	+89.1%	−24.3%	+7.8%	+8.3%	+1.0%
BSX Dec	+12.2%	+7.9%	+8.6%	+9.3%	−7.7%	+19.9%	+6.7%	+12.3%	+17.6%	+19.9%
BTSG Dec	-	-	-	-	-	-	-	+14.3%	+31.0%	+28.2%
GEHC Dec	-	-	-	-	-	-	+4.3%	+6.6%	+0.6%	+4.8%
VTRS Dec	-	-	-	+0.9%	+4.0%	+50.7%	−9.0%	−5.1%	−4.5%	−3.0%
LH Dec	+11.1%	+7.9%	+9.9%	+2.0%	+21.0%	+15.3%	−9.7%	+2.5%	+7.0%	+7.2%
THC Dec	-	−2.2%	−4.5%	+0.9%	−4.5%	+10.5%	−1.6%	+7.2%	+0.5%	+3.1%
Peer median	+12.2%	+7.9%	+7.9%	+2.0%	+2.4%	+19.9%	−3.8%	+6.6%	+4.4%	+4.8%

Gross margin, FY2016 to FY2025

Gross profit / revenue.

UHS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 11.8% to 71.4%. A gap is a year with no number. A ring marks where a line starts: BTSG, GEHC, VTRS have no earlier 10-K here.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
UHS Dec	-	-	-	-	-	-	-	-	-	-
IQV Dec	-	-	-	-	-	-	-	-	-	-
TEVA Dec	53.2%	47.4%	45.4%	44.6%	46.4%	47.8%	46.7%	48.2%	48.7%	51.8%
REGN Dec	-	-	-	-	-	-	-	-	-	-
BSX Dec	65.7%	71.3%	71.4%	71.0%	65.0%	68.8%	68.8%	69.5%	68.6%	69.0%
BTSG Dec	-	-	-	-	-	-	17.5%	14.8%	12.6%	11.8%
GEHC Dec	-	-	-	-	-	40.8%	39.1%	40.5%	41.7%	40.0%
VTRS Dec	-	-	35.0%	33.9%	31.8%	31.2%	40.0%	41.7%	38.2%	35.1%
LH Dec	29.9%	30.0%	28.0%	28.1%	35.4%	38.0%	31.3%	27.7%	27.9%	28.8%
THC Dec	-	-	-	-	-	-	-	-	-	-
Peer median	53.2%	47.4%	40.2%	39.3%	40.9%	40.8%	39.5%	41.1%	39.9%	37.5%

Operating margin, FY2016 to FY2025

Operating income / revenue.

UHS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −78.1% to 55.7%. A gap is a year with no number. A ring marks where a line starts: BTSG, GEHC, VTRS have no earlier 10-K here.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
UHS Dec	13.1%	12.3%	10.9%	10.7%	11.8%	10.8%	7.5%	8.2%	10.6%	11.5%
IQV Dec	8.4%	6.8%	7.1%	7.0%	6.4%	10.0%	12.5%	13.2%	14.3%	13.4%
TEVA Dec	9.8%	−78.1%	−9.0%	−2.6%	−21.4%	10.8%	−14.7%	2.7%	−1.8%	12.5%
REGN Dec	27.4%	35.4%	49.3%	33.7%	42.1%	55.7%	38.9%	30.9%	28.1%	24.9%
BSX Dec	4.9%	14.2%	15.3%	14.1%	−0.8%	10.1%	13.0%	16.5%	15.5%	18.0%
BTSG Dec	-	-	-	-	-	-	2.4%	0.8%	1.1%	2.3%
GEHC Dec	-	-	-	-	-	15.9%	13.8%	12.5%	13.3%	13.4%
VTRS Dec	-	-	7.9%	6.2%	−1.8%	−0.2%	9.9%	5.0%	0.1%	−18.6%
LH Dec	13.3%	12.7%	11.7%	11.5%	17.5%	23.2%	12.1%	6.0%	8.4%	9.9%
THC Dec	5.9%	5.4%	8.9%	8.3%	11.3%	14.7%	12.2%	12.2%	28.8%	16.5%
Peer median	9.1%	9.7%	8.9%	8.3%	6.4%	12.8%	12.2%	12.2%	13.3%	13.4%

Net margin, FY2016 to FY2025

Net income / revenue.

UHS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −72.7% to 50.2%. A gap is a year with no number. A ring marks where a line starts: BTSG, GEHC, VTRS have no earlier 10-K here.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
UHS Dec	7.2%	7.2%	7.2%	7.2%	8.2%	7.8%	5.0%	5.0%	7.2%	8.6%
IQV Dec	1.0%	13.1%	2.5%	1.7%	2.5%	7.0%	7.6%	9.1%	8.9%	8.3%
TEVA Dec	1.5%	−72.7%	−11.8%	−5.9%	−24.0%	2.6%	−16.4%	−3.5%	−9.9%	8.2%
REGN Dec	18.4%	20.4%	47.5%	32.3%	41.3%	50.2%	35.6%	30.1%	31.1%	31.4%
BSX Dec	3.8%	1.1%	17.0%	43.8%	−1.2%	8.3%	5.1%	11.0%	11.1%	14.4%
BTSG Dec	-	-	-	-	-	-	−0.7%	−2.0%	−0.2%	1.5%
GEHC Dec	-	-	-	-	-	12.8%	10.4%	8.0%	10.1%	10.1%
VTRS Dec	-	-	3.1%	0.1%	−5.6%	−7.1%	12.8%	0.4%	−4.3%	−24.6%
LH Dec	7.5%	11.9%	7.8%	7.1%	11.1%	18.1%	10.8%	3.4%	5.7%	6.3%
THC Dec	−0.9%	−3.4%	0.6%	−1.2%	2.3%	4.7%	2.1%	3.0%	15.5%	6.6%
Peer median	2.7%	6.5%	3.1%	1.7%	2.3%	7.6%	7.6%	3.4%	8.9%	8.2%

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

UHS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$317.0M to $6.5B. A gap is a year with no number. A ring marks where a line starts: BTSG, GEHC, VTRS have no earlier 10-K here.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
UHS Dec	$813.9M	$690.1M	$609.8M	$804.4M	$1.6B	$28.0M	$262.0M	$524.7M	$1.1B	$849.2M
IQV Dec	$696.0M	$601.0M	$795.0M	$835.0M	$1.3B	$2.3B	$1.6B	$1.5B	$2.1B	$2.1B
TEVA Dec	$3.0B	$1.4B	$1.8B	$223.0M	$638.0M	$236.0M	$1.0B	$842.0M	$749.0M	$1.1B
REGN Dec	$974.0M	$1.0B	$1.8B	$2.0B	$2.0B	$6.5B	$4.4B	$3.9B	$3.7B	$4.1B
BSX Dec	$806.0M	$1.1B	−$6.0M	$1.4B	$1.1B	$1.3B	$938.0M	$1.8B	$2.6B	$3.7B
BTSG Dec	-	-	-	-	-	-	−$74.8M	$137.3M	−$57.1M	$394.7M
GEHC Dec	-	-	-	-	-	$1.4B	$1.8B	$1.7B	$1.6B	$1.5B
VTRS Dec	-	-	$2.1B	$1.6B	$988.8M	$2.6B	$2.6B	$2.5B	$2.0B	$1.9B
LH Dec	$918.2M	$1.2B	$925.6M	$1.0B	$1.8B	$2.7B	$1.5B	$874.1M	$1.1B	$1.2B
THC Dec	−$317.0M	$493.0M	$432.0M	$563.0M	$2.9B	$910.0M	$321.0M	$1.6B	$1.1B	$2.5B
Peer median	$862.1M	$1.1B	$925.6M	$1.0B	$1.3B	$1.8B	$1.5B	$1.6B	$1.6B	$1.9B

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

UHS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −1.5% to 40.6%. A gap is a year with no number. A ring marks where a line starts: BTSG, GEHC, VTRS have no earlier 10-K here.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
UHS Dec	8.3%	6.6%	5.7%	7.1%	14.1%	0.2%	2.0%	3.7%	7.1%	4.9%
IQV Dec	10.1%	6.2%	7.6%	7.5%	11.8%	16.6%	11.0%	10.0%	13.7%	12.6%
TEVA Dec	13.6%	6.0%	9.8%	1.3%	3.8%	1.5%	7.0%	5.3%	4.5%	6.7%
REGN Dec	20.0%	17.6%	35.2%	30.5%	23.6%	40.6%	36.3%	29.5%	25.8%	28.4%
BSX Dec	8.9%	12.2%	−0.1%	12.8%	11.4%	11.1%	7.4%	12.6%	15.8%	18.2%
BTSG Dec	-	-	-	-	-	-	−1.0%	1.8%	−0.6%	3.1%
GEHC Dec	-	-	-	-	-	7.7%	9.9%	8.8%	7.9%	7.3%
VTRS Dec	-	-	18.3%	13.8%	8.3%	14.3%	15.9%	16.4%	13.4%	13.5%
LH Dec	9.6%	11.5%	8.2%	9.0%	12.5%	20.5%	12.9%	7.2%	8.4%	8.6%
THC Dec	−1.5%	2.4%	2.4%	3.0%	16.3%	4.7%	1.7%	7.9%	5.4%	11.9%
Peer median	9.9%	8.8%	8.2%	9.0%	11.8%	12.7%	9.9%	8.8%	8.4%	11.9%

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

UHS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −93.7% to 88.9%. A gap is a year with no number. A ring marks where a line starts: BTSG, GEHC, VTRS have no earlier 10-K here.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
UHS Dec	15.5%	15.1%	14.5%	14.8%	14.9%	16.3%	11.4%	11.7%	17.1%	20.5%
IQV Dec	0.8%	16.0%	3.9%	3.2%	4.6%	16.0%	18.9%	22.2%	22.6%	20.9%
TEVA Dec	1.0%	−93.7%	−14.6%	−7.2%	−39.8%	4.1%	−31.3%	−7.4%	−30.5%	17.8%
REGN Dec	20.1%	19.5%	27.9%	19.1%	31.9%	43.0%	19.1%	15.2%	15.0%	14.4%
BSX Dec	5.2%	1.5%	19.1%	33.9%	−0.8%	5.9%	3.7%	8.1%	8.5%	12.0%
BTSG Dec	-	-	-	-	-	-	−7.1%	−26.4%	−1.1%	10.2%
GEHC Dec	-	-	-	-	-	13.5%	20.5%	22.0%	23.6%	20.1%
VTRS Dec	-	-	2.9%	n/m	−2.9%	−6.2%	9.9%	0.3%	−3.4%	−23.9%
LH Dec	12.9%	18.0%	12.5%	10.8%	16.5%	23.1%	12.7%	5.3%	9.3%	10.2%
THC Dec	−46.0%	n/m	n/m	n/m	n/m	88.9%	36.0%	38.0%	76.7%	33.3%
Peer median	3.1%	16.0%	8.2%	10.8%	1.9%	14.7%	12.7%	8.1%	9.3%	14.4%

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

UHS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 0.00 to 15.22. A gap is a year with no number. A ring marks where a line starts: REGN, BTSG, GEHC, VTRS, THC have no earlier 10-K here.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
UHS Dec	0.91	0.81	0.74	0.72	0.61	0.69	0.81	0.80	0.68	0.66
IQV Dec	0.84	1.28	1.64	1.94	2.09	2.01	2.21	2.24	2.30	2.42
TEVA Dec	0.98	1.66	1.97	1.93	2.59	2.24	2.72	2.64	3.31	2.12
REGN Dec	-	-	-	0.00	0.18	0.11	0.09	0.08	0.07	0.06
BSX Dec	0.80	0.80	0.81	0.72	0.60	0.55	0.51	0.47	0.49	0.47
BTSG Dec	-	-	-	-	-	-	-	5.75	1.58	1.34
GEHC Dec	-	-	-	-	-	-	0.88	1.46	1.24	1.01
VTRS Dec	-	-	-	n/m	1.13	1.13	0.91	0.89	0.75	0.98
LH Dec	1.05	0.99	0.85	0.87	0.61	0.53	0.53	0.64	0.79	0.65
THC Dec	n/m	n/m	n/m	n/m	n/m	15.22	13.20	9.33	3.16	3.12
Peer median	0.91	1.13	1.25	0.87	0.87	1.13	0.90	1.46	1.24	1.01

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

UHS is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$16.26 to $71.97. A gap is a year with no number. A ring marks where a line starts: BTSG, GEHC, VTRS have no earlier 10-K here.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
UHS Dec	$7.14	$7.81	$8.31	$9.13	$10.99	$11.82	$9.14	$10.23	$16.82	$23.10
IQV Dec	$0.47	$5.74	$1.24	$0.96	$1.43	$4.95	$5.72	$7.29	$7.49	$7.84
TEVA Dec	$0.07	−$16.26	−$2.35	−$0.91	−$3.64	$0.38	−$2.20	−$0.50	−$1.45	$1.21
REGN Dec	$7.70	$10.34	$21.29	$18.46	$30.52	$71.97	$38.22	$34.77	$38.34	$41.48
BSX Dec	$0.25	$0.08	$1.19	$3.33	−$0.08	$0.69	$0.45	$1.07	$1.25	$1.94
BTSG Dec	-	-	-	-	-	-	−$0.46	−$1.31	−$0.09	$0.87
GEHC Dec	-	-	-	-	-	$4.95	$4.22	$3.03	$4.34	$4.55
VTRS Dec	-	-	$0.68	$0.03	−$1.11	−$1.05	$1.71	$0.05	−$0.53	−$3.00
LH Dec	$6.82	$11.81	$8.61	$8.35	$15.88	$24.39	$13.97	$4.77	$8.84	$10.46
THC Dec	−$1.93	−$7.00	$1.00	−$2.08	$3.75	$8.42	$3.79	$5.71	$32.70	$15.49
Peer median	$0.36	$2.91	$1.19	$0.96	$1.43	$4.95	$3.79	$3.03	$4.34	$4.55

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out UHS and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more

Sources

Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.

Also

Financials: UHS's own statements, year by year. Compare: the whole peer group on one page.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/UHS/export.csv") into a cell.

Next:Industry numbers